Recruiting Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study NCT05019703 Conditions Locally Advanced Osteosarcoma, Metastatic Osteosarcoma, Neoplasms, +9 more Locations Dana-Farber Cancer Institute — Boston, Massachusetts, United States M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
Active, Not Recruiting Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma NCT02243605 Conditions Metastatic Ewing Sarcoma, Metastatic Osteosarcoma, Neoplasms, +15 more Locations Institut Bergonie Cancer Center — Bordeaux, France Centre Georges-Francois Leclerc — Dijon, France Centre Oscar Lambert — Lille, France Centre Leon Berard — Lyon, France View more locations Show fewer locations Loading locations... View Trial Details
